Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner
Soohyun P. Kim, … , Michael J. Wolfgang, Ryan C. Riddle
Soohyun P. Kim, … , Michael J. Wolfgang, Ryan C. Riddle
Published August 17, 2017
Citation Information: JCI Insight. 2017;2(16):e92704. https://doi.org/10.1172/jci.insight.92704.
View: Text | PDF
Research Article Bone biology

Fatty acid oxidation by the osteoblast is required for normal bone acquisition in a sex- and diet-dependent manner

  • Text
  • PDF
Abstract

Postnatal bone formation is influenced by nutritional status and compromised by disturbances in metabolism. The oxidation of dietary lipids represents a critical source of ATP for many cells but has been poorly studied in the skeleton, where the prevailing view is that glucose is the primary energy source. Here, we examined fatty acid uptake by bone and probed the requirement for fatty acid catabolism during bone formation by specifically disrupting the expression of carnitine palmitoyltransferase 2 (Cpt2), an obligate enzyme in fatty acid oxidation, in osteoblasts and osteocytes. Radiotracer studies demonstrated that the skeleton accumulates a significant fraction of postprandial fatty acids, which was equal to or in excess of that acquired by skeletal muscle or adipose tissue. Female, but not male, Cpt2 mutant mice exhibited significant impairments in postnatal bone acquisition, potentially due to an inability of osteoblasts to modify fuel selection. Intriguingly, suppression of fatty acid utilization by osteoblasts and osteocytes also resulted in the development of dyslipidemia and diet-dependent modifications in body composition. Taken together, these studies demonstrate a requirement for fatty acid oxidation during bone accrual and suggest a role for the skeleton in lipid homeostasis.

Authors

Soohyun P. Kim, Zhu Li, Meredith L. Zoch, Julie L. Frey, Caitlyn E. Bowman, Priyanka Kushwaha, Kathleen A. Ryan, Brian C. Goh, Susanna Scafidi, Julie E. Pickett, Marie-Claude Faugere, Erin E. Kershaw, Daniel L. J. Thorek, Thomas L. Clemens, Michael J. Wolfgang, Ryan C. Riddle

×

Figure 3

In vitro differentiation of osteoblasts is impaired following the ablation of Cpt2 expression.

Options: View larger image (or click on image) Download as PowerPoint
In vitro differentiation of osteoblasts is impaired following the ablati...
(A) qPCR analysis of Cpt2 mRNA levels in primary osteoblasts after infection with adenoviral constructs encoding GFP (control) or Cre-recombinase (ΔCpt2) (n = 6). (B) Relative levels of [14C]-oleate oxidation to 14CO2 (n = 7). (C) Oxygen consumption rate (OCR) in control and ΔCpt2 osteoblasts in the presence of 200 μM oleate (n = 16). (D) qPCR analysis of genes associated with osteoblastic differentiation in control and ΔCpt2 osteoblasts cultured in the presence or absence of 10 nM 17β-estradiol (E2) (n = 5). (E) Staining for alkaline phosphatase activity (AP) on days 7 and 14 of in vitro differentiation and calcium deposition by alizarin red (ARS) on day 14 in cultures of control and ΔCpt2 osteoblasts. (F) Quantification of relative ARS levels (n = 6). (G) Relative levels of 2-deoxy-D-[3H]-glucose uptake in control and ΔCpt2 osteoblasts cultured in the presence or absence of E2 (n = 6). (H) Cellular lactate levels in control and ΔCpt2 osteoblasts (n = 5). (I) qPCR analysis of genes associated with glucose metabolism in control and ΔCpt2 osteoblasts cultured in the presence or absence of E2 (n = 5). (J and K) OCR (J) and extracellular acidification rate (ECAR, K) were assessed in osteoblasts cultured in the presence of 2.5 mM glucose (n = 15–16). (L) Relative levels of [14C]-glutamine uptake (n = 11–12). (M) Cellular ATP in control and ΔCpt2 osteoblasts (n = 10–12). (N) Immunoblots showing AMPK phosphorylation levels (representative of n = 4). All data are represented by mean ± SEM. *P < 0.05 by unpaired, two-tailed Student’s t test or ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts